Abstract
There is an interest and need for non-dietary therapies for celiac disease. Recent regulatory meetings and expert consensus have set some guidance for clinical trials designs and drug development in this disease that has a unique paradigm. Several agents are currently being trialed and act on immune tolerance with antigen-specific therapeutics, preventing the absorption and effects of gluten immunogenic peptides and immune modulation.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 803-822 |
| Number of pages | 20 |
| Journal | Gastrointestinal Endoscopy Clinics of North America |
| Volume | 35 |
| Issue number | 4 |
| DOIs | |
| State | Published - Oct 2025 |
Keywords
- Celiac disease
- Clinical trials
- Drug development
- Drug therapies
- Gluten-free diet
ASJC Scopus subject areas
- Gastroenterology
Fingerprint
Dive into the research topics of 'Drugs in Development and Clinical Trials for Celiac Disease'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS